‘Selected’ Exosomes from Sera of Elderly Severe Obstructive Sleep Apnea Patients and Their Impact on Blood–Brain Barrier Function: A Preliminary Report
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms252011058 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Pauline Guillot und 4 weiteren Autor:innen. Beteiligte Einrichtung: Gérontopôle AURA, 42000 Saint-Etienne, France. Hauptthemen laut MEDLINE: Exosomes, Blood-Brain Barrier, Sleep Apnea, Obstructive, tau Proteins. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Gérontopôle AURA, Association Nationale de la Recherche et de la Technologie (ANRT).
Abstract (Originalsprache)
Obstructive sleep apnea syndrome (OSAS) affects a large part of the aging population. It is characterized by chronic intermittent hypoxia and associated with neurocognitive dysfunction. One hypothesis is that the blood–brain barrier (BBB) functions could be altered by exosomes. Exosomes are nanovesicles found in biological fluids. Through the study of exosomes and their content in tau and amyloid beta (Aβ), the aim of this study was to show how exosomes could be used as biomarkers of OSAS and of their cognitive disorders. Two groups of 15 volunteers from the PROOF cohort were selected: severe apnea (AHI > 30) and control (AHI < 5). After exosome isolation from blood serum, we characterized and quantified them (CD81, CD9, CD63) by western blot and ELISAs and put them 5 h in contact with an in vitro BBB model. The apparent permeability of the BBB was measured using sodium-fluorescein and TEER. Cell ELISAs were performed on tight junctions (ZO-1, claudin-5, occludin). The amount of tau and Aβ proteins found in the exosomes was quantified using ELISAs. Compared to controls, OSAS patients had a greater quantity of exosomes, tau, and Aβ proteins in their blood sera, which induced an increase in BBB permeability in the model and was reflected by a loss of tight junction’ expression. Elderly patients suffering severe OSAS released more exosomes in serum from the brain compartment than controls. Such exosomes increased BBB permeability. The impact of such alterations on the risk of developing cognitive dysfunction and/or neurodegenerative diseases is questioned.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Gérontopôle AURA, 42000 Saint-Etienne, France.
- Inserm, U1059, Sainbiose, Faculté de Médecine Jacques Lisfranc, Université de Lyon, 42000 Saint-Etienne, France.
- Faculté de Médecine Jacques Lisfranc, Université Jean Monnet, 42000 Saint-Etienne, France.
- Physiologie Clinique et de l'Exercice, Centre Visas, CHU Saint Etienne, 42000 Saint-Etienne, France.
- Chaire Santé des Ainés, Ingénierie de la Prévention, Université Jen Monnet, 42000 Saint-Etienne, France.
ORCID-Profile: Frederic Roche
Förderung
- Gérontopôle AURA
- Association Nationale de la Recherche et de la Technologie (ANRT)
Zitieren
APA
Guillot, P., Celle, S., Barth, N., Roche, F., & Perek, N. (2024). ‘Selected’ Exosomes from Sera of Elderly Severe Obstructive Sleep Apnea Patients and Their Impact on Blood–Brain Barrier Function: A Preliminary Report. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms252011058
Vancouver
Guillot P, Celle S, Barth N, Roche F, Perek N. ‘Selected’ Exosomes from Sera of Elderly Severe Obstructive Sleep Apnea Patients and Their Impact on Blood–Brain Barrier Function: A Preliminary Report. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms252011058
BibTeX
@article{Guillot2024,
author = {Guillot, Pauline and Celle, Sebastien and Barth, Nathalie and Roche, Frederic and Perek, Nathalie},
title = {‘Selected’ Exosomes from Sera of Elderly Severe Obstructive Sleep Apnea Patients and Their Impact on Blood–Brain Barrier Function: A Preliminary Report},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms252011058}
}
EUVIMED